Effect of FK506 on the activation state of hepatic macrophages in Propionibacterium acnes-treated rats.
Activated hepatic macrophages can provoke massive liver necrosis following endotoxin stimulation through microcirculatory disturbances due to sinusoidal fibrin deposition in rats pretreated with heat-killed Propionibacterium acnes. In these rats, FK506 (tachlorinus) administered 24 h before and at the time of endotoxin injection, significantly attenuated liver injury compared with the rats given no FK506. The effect of FK506 on hepatic macrophage activation and its action sites were studied in Propionibacterium acnes-treated rats. When rats received Propionibacterium acnes intravenously, hepatic-mRNA expression of interferon-gamma-inducing factor and interleukin-2 and splenic-mRNA expression of interferon-gamma were significantly increased compared with normal rats. Hepatic-mRNA expression of CD14, a receptor for lipopolysaccharide and its binding protein complex, was also increased preceding the expressions of the three cytokines in the liver and spleen. FK506 administration attenuated hepatic-mRNA expression of interleukin-2 and both superoxide anions as well as tumour necrosis factor-alpha production by hepatic macrophages, but did not change CD14-mRNA expression in Propionibacterium acnes-treated rats. It is suggested that a cytokine network through interferon-gamma-inducing factor, interferon-gamma and interleukin-2 may operate during activation of hepatic macrophages in rats treated with heat-killed Propionibacterium acnes, while CD14 expression on the cells may increase independently of this network. FK506 seems to attenuate such activation by suppressing hepatic interleukin-2 expression, without affecting CD14 expression on the cells.
Toshima
K
K
Third Department of Internal Medicine, Saitama Medical School, Japan.
Mochida
S
S
Arai
S
S
Ishikawa
K
K
Matsui
A
A
Fujiwara
K
K
D000818:Animals; D016207:Cytokines / Q000502:physiology; D016908:Gram-Positive Bacterial Infections / Q000503:physiopathology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008099:Liver / Q000166:cytology / Q000502:physiology*; D008264:Macrophages / Q000502:physiology*; D011425:Propionibacterium acnes; D051381:Rats; D016559:Tacrolimus / Q000494:pharmacology*
D016207:Cytokines; D007166:Immunosuppressive Agents; D016559:Tacrolimus